Cargando…
A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment
BACKGROUND: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The International AIDS Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297518/ https://www.ncbi.nlm.nih.gov/pubmed/22340703 http://dx.doi.org/10.1186/1758-2652-15-7 |
_version_ | 1782225879006445568 |
---|---|
author | Braitstein, Paula Siika, Abraham Hogan, Joseph Kosgei, Rose Sang, Edwin Sidle, John Wools-Kaloustian, Kara Keter, Alfred Mamlin, Joseph Kimaiyo, Sylvester |
author_facet | Braitstein, Paula Siika, Abraham Hogan, Joseph Kosgei, Rose Sang, Edwin Sidle, John Wools-Kaloustian, Kara Keter, Alfred Mamlin, Joseph Kimaiyo, Sylvester |
author_sort | Braitstein, Paula |
collection | PubMed |
description | BACKGROUND: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. METHODS: The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of ≤100 cells/mm(3). All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of ≤100 cells/mm(3 )were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. RESULTS: Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of ≤100 cells/mm(3). After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). CONCLUSIONS: Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings. |
format | Online Article Text |
id | pubmed-3297518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | The International AIDS Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-32975182012-03-09 A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment Braitstein, Paula Siika, Abraham Hogan, Joseph Kosgei, Rose Sang, Edwin Sidle, John Wools-Kaloustian, Kara Keter, Alfred Mamlin, Joseph Kimaiyo, Sylvester J Int AIDS Soc Research BACKGROUND: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. METHODS: The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of ≤100 cells/mm(3). All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of ≤100 cells/mm(3 )were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. RESULTS: Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of ≤100 cells/mm(3). After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). CONCLUSIONS: Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings. The International AIDS Society 2012-02-17 /pmc/articles/PMC3297518/ /pubmed/22340703 http://dx.doi.org/10.1186/1758-2652-15-7 Text en Copyright ©2012 Braitstein et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Braitstein, Paula Siika, Abraham Hogan, Joseph Kosgei, Rose Sang, Edwin Sidle, John Wools-Kaloustian, Kara Keter, Alfred Mamlin, Joseph Kimaiyo, Sylvester A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment |
title | A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment |
title_full | A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment |
title_fullStr | A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment |
title_full_unstemmed | A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment |
title_short | A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment |
title_sort | clinician-nurse model to reduce early mortality and increase clinic retention among high-risk hiv-infected patients initiating combination antiretroviral treatment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297518/ https://www.ncbi.nlm.nih.gov/pubmed/22340703 http://dx.doi.org/10.1186/1758-2652-15-7 |
work_keys_str_mv | AT braitsteinpaula acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT siikaabraham acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT hoganjoseph acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT kosgeirose acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT sangedwin acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT sidlejohn acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT woolskaloustiankara acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT keteralfred acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT mamlinjoseph acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT kimaiyosylvester acliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT braitsteinpaula cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT siikaabraham cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT hoganjoseph cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT kosgeirose cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT sangedwin cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT sidlejohn cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT woolskaloustiankara cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT keteralfred cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT mamlinjoseph cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment AT kimaiyosylvester cliniciannursemodeltoreduceearlymortalityandincreaseclinicretentionamonghighriskhivinfectedpatientsinitiatingcombinationantiretroviraltreatment |